Systemic lupus erythematosus
Identifieur interne : 002A17 ( Main/Exploration ); précédent : 002A16; suivant : 002A18Systemic lupus erythematosus
Auteurs : Marisa S. Klein-Gitelman [États-Unis] ; Michael L. Miller [États-Unis]Source :
- The Indian Journal of Pediatrics [ 0019-5456 ] ; 1996-07-01.
English descriptors
- KwdEn :
- Teeft :
- Active disease, Apoptosis, Arthritis, Arthritis rheum, Clin, Congenital heart block, Cyclophosphamide, Diagnostic criteria, Disease activity, Disease flare, Erythematosus, Immune, Immune complexes, Indian journal, Lupus, Lupus erythematosus, Lupus nephritis, Lupus patients, Lymphocyte, Magnetic resonance imaging, Malar rash, Medication, Nephritis, Overlap syndromes, Pediatr, Pediatr clin, Pediatric, Pediatric rheumatology, Pediatrics, Rash, Renal, Renal disease, Rheum, Rheumatic diseases, Rheumatology, Self antigens, Serologic, Steroid, Syndrome, Systemic, Systemic lupus erythematosus, Target organs.
Abstract
Abstract: Systemic Lupus Erythematosus (SLE) of childhood is a complex and challenging disease which can occur at any age. Identification of disease early in it's course and aggressive, appropriate management leads to improved outcome for an individual child. The history of SLE indicates how much progress has been made in the last quarter century. A discussion of the etiopathogenesis of SLE demonstrates the complexity of the syndrome. This is followed by a description of clinical manifestations, including diagnostic criteria, differential diagnosis and suggested methods for eliciting important symptoms to make the diagnosis. Evaluation of specific organs is next reviewed highlighting critical organ manifestations that are significant for future prognosis. Treatment of SLE includes a variety of medications, including non-steroidal anti-inflammatory medications, steroids and immuno-suppressive drugs. Attention to physical activity, stress and nutrition is equally important. Signs and symptoms that indicate disease flare or infection are described. Lastly, related syndromes are reviewed.
Url:
DOI: 10.1007/BF02905723
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002670
- to stream Istex, to step Curation: 002670
- to stream Istex, to step Checkpoint: 001807
- to stream Main, to step Merge: 002A69
- to stream Main, to step Curation: 002A17
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Systemic lupus erythematosus</title><author><name sortKey="Klein Gitelman, Marisa S" sort="Klein Gitelman, Marisa S" uniqKey="Klein Gitelman M" first="Marisa S." last="Klein-Gitelman">Marisa S. Klein-Gitelman</name></author><author><name sortKey="Miller, Michael L" sort="Miller, Michael L" uniqKey="Miller M" first="Michael L." last="Miller">Michael L. Miller</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6F8CBB4E19792D7172543653CB1BE64CC1E4E88E</idno><date when="1996" year="1996">1996</date><idno type="doi">10.1007/BF02905723</idno><idno type="url">https://api.istex.fr/ark:/67375/1BB-ZKXHLVRK-2/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002670</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002670</idno><idno type="wicri:Area/Istex/Curation">002670</idno><idno type="wicri:Area/Istex/Checkpoint">001807</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001807</idno><idno type="wicri:doubleKey">0019-5456:1996:Klein Gitelman M:systemic:lupus:erythematosus</idno><idno type="wicri:Area/Main/Merge">002A69</idno><idno type="wicri:Area/Main/Curation">002A17</idno><idno type="wicri:Area/Main/Exploration">002A17</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Systemic lupus erythematosus</title><author><name sortKey="Klein Gitelman, Marisa S" sort="Klein Gitelman, Marisa S" uniqKey="Klein Gitelman M" first="Marisa S." last="Klein-Gitelman">Marisa S. Klein-Gitelman</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Immunology and Rheumatology, Children's Memorial Hospital and Northwestern University Medical School, 2300 Children's Plaza, 60614, Chicago, IL</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Pediatrics, Children's Memorial Hospital and Northwestern University Medical School, 2300 Children's Plaza, 60614, Chicago, IL</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Miller, Michael L" sort="Miller, Michael L" uniqKey="Miller M" first="Michael L." last="Miller">Michael L. Miller</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Immunology and Rheumatology, Children's Memorial Hospital and Northwestern University Medical School, 2300 Children's Plaza, 60614, Chicago, IL</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Pediatrics, Children's Memorial Hospital and Northwestern University Medical School, 2300 Children's Plaza, 60614, Chicago, IL</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">The Indian Journal of Pediatrics</title><title level="j" type="abbrev">Indian J Pediatr</title><idno type="ISSN">0019-5456</idno><idno type="eISSN">0973-7693</idno><imprint><publisher>Springer India</publisher><pubPlace>New Delhi</pubPlace><date type="published" when="1996-07-01">1996-07-01</date><biblScope unit="volume">63</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="485">485</biblScope><biblScope unit="page" to="500">500</biblScope></imprint><idno type="ISSN">0019-5456</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0019-5456</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies</term><term>Medications</term><term>Related syndromes</term><term>SLE</term></keywords><keywords scheme="Teeft" xml:lang="en"><term>Active disease</term><term>Apoptosis</term><term>Arthritis</term><term>Arthritis rheum</term><term>Clin</term><term>Congenital heart block</term><term>Cyclophosphamide</term><term>Diagnostic criteria</term><term>Disease activity</term><term>Disease flare</term><term>Erythematosus</term><term>Immune</term><term>Immune complexes</term><term>Indian journal</term><term>Lupus</term><term>Lupus erythematosus</term><term>Lupus nephritis</term><term>Lupus patients</term><term>Lymphocyte</term><term>Magnetic resonance imaging</term><term>Malar rash</term><term>Medication</term><term>Nephritis</term><term>Overlap syndromes</term><term>Pediatr</term><term>Pediatr clin</term><term>Pediatric</term><term>Pediatric rheumatology</term><term>Pediatrics</term><term>Rash</term><term>Renal</term><term>Renal disease</term><term>Rheum</term><term>Rheumatic diseases</term><term>Rheumatology</term><term>Self antigens</term><term>Serologic</term><term>Steroid</term><term>Syndrome</term><term>Systemic</term><term>Systemic lupus erythematosus</term><term>Target organs</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Systemic Lupus Erythematosus (SLE) of childhood is a complex and challenging disease which can occur at any age. Identification of disease early in it's course and aggressive, appropriate management leads to improved outcome for an individual child. The history of SLE indicates how much progress has been made in the last quarter century. A discussion of the etiopathogenesis of SLE demonstrates the complexity of the syndrome. This is followed by a description of clinical manifestations, including diagnostic criteria, differential diagnosis and suggested methods for eliciting important symptoms to make the diagnosis. Evaluation of specific organs is next reviewed highlighting critical organ manifestations that are significant for future prognosis. Treatment of SLE includes a variety of medications, including non-steroidal anti-inflammatory medications, steroids and immuno-suppressive drugs. Attention to physical activity, stress and nutrition is equally important. Signs and symptoms that indicate disease flare or infection are described. Lastly, related syndromes are reviewed.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Illinois</li></region></list><tree><country name="États-Unis"><region name="Illinois"><name sortKey="Klein Gitelman, Marisa S" sort="Klein Gitelman, Marisa S" uniqKey="Klein Gitelman M" first="Marisa S." last="Klein-Gitelman">Marisa S. Klein-Gitelman</name></region><name sortKey="Klein Gitelman, Marisa S" sort="Klein Gitelman, Marisa S" uniqKey="Klein Gitelman M" first="Marisa S." last="Klein-Gitelman">Marisa S. Klein-Gitelman</name><name sortKey="Miller, Michael L" sort="Miller, Michael L" uniqKey="Miller M" first="Michael L." last="Miller">Michael L. Miller</name><name sortKey="Miller, Michael L" sort="Miller, Michael L" uniqKey="Miller M" first="Michael L." last="Miller">Michael L. Miller</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A17 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002A17 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:6F8CBB4E19792D7172543653CB1BE64CC1E4E88E
|texte= Systemic lupus erythematosus
}}
| This area was generated with Dilib version V0.6.33. |  |